Search for: "Hui Zhang" Results 1 - 20 of 29
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Mar 2021, 10:51 am
Ted Hui from the Democratic Party subsequently marched forward and spilt liquid on the floor before being removed by security.[7]   Together this theater of legislative action provided the appropriate backdrop to the longer term spectacle, the continuous gesture, that  is the National Anthem Ordinance. [read post]
23 Jul 2020, 4:00 am by Jon L. Gelman
The rapid emergence of COVID-19 creates new challenges for the nation’s patchwork of state run workplace benefit delivery systems. [read post]
18 Oct 2019, 2:31 am by Hui Zhang
Hui Zhang, Binxin Li and Leon LiChinese courts heavily rely on evidence to rule a case, and conventionally, notarization is basically the only option when a party collects evidence by itself. [read post]
15 Aug 2019, 7:19 pm by Hui Zhang
Hui Zhang, Xiang Li and Hui ZhangDeclaratory-judgment actions of non-infringement are common in patent litigation because it allows the alleged infringer to proactively bring suit to resolve the situation and eliminate the cloud of uncertainty looming overhead. [read post]
4 Aug 2019, 1:26 pm by Bill Marler
Thanks to the New York Times and Matt Richtel for “Tainted Pork, Ill Consumers and an Investigation Thwarted. [read post]
13 Jun 2019, 7:16 pm by Hui Zhang
Hui Zhang and Hui ZhangAfter several rounds of revisions, the latest draft of the 4th amendment of the Patent Law was released by the Standing Committee of the National People’s Congress (“NPC”) after its first reading in December 2018. [read post]
18 Apr 2019, 3:55 am by Hui Zhang
Hui Zhang, Xiang Li and Hanmei WangIn our blog of last December, we reported that China has established a new IP Tribunal within the Supreme People’s Court (the “SPC”) as a national IP appellate court akin to the federal circuit in the United States. [read post]
19 Feb 2019, 3:15 am by Hui Zhang
Hui Zhang, Yi Wei and Jiao YuxinThe Supreme People’s Court of China recently issued a new judicial interpretation regarding preliminary injunctions (PI) for intellectual property (IP) disputes that took effect on January 1, 2019, officially titled “Provisions of The Supreme People’s Court on Several Issues Concerning the Application of Laws in Adjudication of Action Preservation Cases Involving IP Disputes” (Provisions). [read post]
20 Dec 2018, 6:10 pm by Hui Zhang
Hui Zhang, Junkun Zheng and James YangOn October 26, 2018, China’s National People’s Congress (NPC) issued a Decision, approving the establishment of a new IP Tribunal within the Supreme People’s Court (the “SPC”) as a national IP appellate court akin to the role of the Court of Appeals for the Federal Circuit (the “CAFC”) in the United States. 1. [read post]
16 Oct 2018, 6:41 pm by Hui Zhang
Hui Zhang, Xiang Li and Yin LiIn China, a patent owner’s statements made during prosecution or invalidation may give rise to prosecution history estoppel (or prosecution disclaimer), which precludes the patent owner from recapturing subject matter that was relinquished during prosecution or invalidation in subsequent infringement actions. [read post]
15 Aug 2018, 12:48 am by Hui Zhang
Hui Zhang, Yi Wei and Jiao YuxinA Markush claim is a type of claim commonly used in chemical and pharmaceutical fields. [read post]
29 May 2018, 10:47 am by Hui Zhang
Hui Zhang, Mengling Liu and James Yang  On March 28, 2018, the Beijing High Court issued its decision for Iwncomm v. [read post]
3 Apr 2018, 7:12 am by Hui Zhang
Hui Zhang, Xiang Li, Dani Min and Jiao YuxinOn October 8, 2017, the Chinese Communist Party and the State Council jointly issued a special opinion on the reform of drug and medical device approval system (“Innovation Opinion”). [read post]
6 Jun 2017, 12:53 am by Hui Zhang
Hui Zhang, Xiang Li and Hanmei WangOn March 22, 2017, the Beijing IP Court (the “trial court”) issued a decision on a high-profile case Iwncomm v. [read post]
4 May 2017, 1:00 am by Jiao Yuxin
Jiao Yuxin, Hui Zhang and Yi WeiPharmaceutical polymorph patents are regarded as effective means and important secondary pharmaceutical patents to extend the life cycle of pharmaceutical patent protection. [read post]
11 Feb 2017, 5:25 am
This is another in the series of essays that were presented at the “来华外国人与近代中国法” 国际学术研讨会 "Foreigners and Modern Chinese Law" International Symposium Conference and then continued thereafter in the same spirit.No.175-1 章永乐:旧邦新造的历史文化基因; No. 175 No.175-1… [read post]
10 Feb 2017, 12:40 am by Hui Zhang
Hui Zhang, Jiao Yuxin and Dani MinZY PartnersA positive view is spreading on post-filing experimental data in China since the recent official post of the proposed revisions to the Guidelines for Patent Examination (the “Guidelines”) by the State IP Office (the “SIPO”) of China. [read post]
13 Jul 2016, 9:03 pm
Gareau, Obstacles to preserving precaution and equity in global hazardous waste regulation: an analysis of contested knowledge in the Basel Convention Jon Birger Skjærseth, Linking EU climate and energy policies: policy-making, implementation and reform José Octavio Velázquez Gomar, Environmental policy integration among multilateral environmental agreements: the case of biodiversity David Belis & Bart Kerremans, The socialization potential of the CDM in EU–China… [read post]